Kevin Hern: “To say that it did not attribute to the Tax Code would be to call those individual CEOs liars.”

It is sad that what we are dealing with is stifled innovation and a decrease in patient access due to the Inflation Reduction Act.

It is critical that we keep innovation here in the U.S., but it is also critical that we make sure healthcare is affordable.

One way to do this is by reducing the regulatory burden so that Title IV-B funding recipients can spend more time helping children and families, and less time waiting through the red tape.

But I still think the right thing to do is to get our government under control. We’re $37 trillion in debt and growing.